This review highlights advances made in recent years in the diagnosis and management of
acute pancreatitis (AP). We focus on epidemiological, clinical, and management aspects of …

Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or
indomethacin immediately before endoscopic retrograde cholangiopancreatography …

Endoscopic retrograde cholangiopancreatography (ERCP) plays a significant role in the
treatment of a vast array of pancreatobiliary diseases. However, despite significant progress …

Abstract Objectives Post-ERCP pancreatitis (PEP) is a life-threatening complication. Given
the lack of a causative treatment for pancreatitis, it is of vital importance to minimize this risk …

Methods: We conducted a comparative effectiveness, multicenter, double-blinded,
randomized trial of rectal indomethacin alone vs a combination of rectal indomethacin and …

Acute post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is a feared
and potentially fatal complication that can be as high as up to 30% in high-risk patients. Pre …

Despite recent advances in prevention, the incidence of pancreatitis after endoscopic
retrograde cholangiopancreatography (ERCP) remains 3% to 15%, resulting in substantial …

Endoscopic retro-grade cholangiopancreatography (ERCP) was developed in 1968 and
almost instantly gained a key role in the diagnosis and management of many biliopancreatic …

Background: Endoscopic retrograde cholangiopancreatography (ERCP) has an important
role in the treatment of pancreaticobiliary disorders. Goals: Considering the high prevalence …

Objectives Both pancreatic stenting and rectal nonsteroidal anti-inflammatory drugs
(NSAIDs) prevent post–endoscopic retrograde cholangiopancreatography (ERCP) …